医学
脑出血
临床试验
冲程(发动机)
血肿
重症监护医学
人口
麻醉
外科
内科学
格拉斯哥昏迷指数
机械工程
环境卫生
工程类
作者
David Wilkinson,Aditya S. Pandey,B. Gregory Thompson,Richard F. Keep,Ya Hua,Guohua Xi
标识
DOI:10.1016/j.neuropharm.2017.09.033
摘要
Intracerebral hemorrhage (ICH) is the most common hemorrhagic stroke subtype, and rates are increasing with an aging population. Despite an increase in research and trials of therapies for ICH, mortality remains high and no interventional therapy has been demonstrated to improve outcomes. We review known mechanisms of injury, recent clinical trial results, and newly discovered signaling pathways involved in hematoma clearance. Enthusiasm remains high for methods of minimally invasive clot removal as well as pharmacologic strategies to improve recovery after ICH, both of which are currently being evaluated in clinical trials. This article is part of the Special Issue entitled ‘Cerebral Ischemia’.
科研通智能强力驱动
Strongly Powered by AbleSci AI